[Skip to Content]
[Skip to Content Landing]
Citations 0
Capitol Health Call
October 12, 2005

Plan B Deferred

JAMA. 2005;294(14):1752. doi:10.1001/jama.294.14.1752-b

Department of Health and Human Services Secretary Michael Leavitt and the Food and Drug Administration (FDA) broke their promise to decide by September 1 on whether to approve over-the-counter sales of the emergency contraceptive called Plan B by its manufacturer, Barr Laboratories Inc, charged Senators Hillary Rodham Clinton (D, NY) and Patty Murray (D, Wash).

“It is a breach of faith to have this administration give us their word that a decision would be made, and have that promise violated. FDA’s only criteria for approval should be safety and efficacy, not politics and ideology,” Clinton and Murray said in a statement. They had dropped their hold on the nomination of Lester Crawford, PhD, DVM, to head the FDA based on Leavitt’s promise of a decision by September 1.

First Page Preview View Large
First page PDF preview
First page PDF preview